P&G Q3 sales rise 7%, core EPS up 3%; fiscal EPS now seen toward low end of range
Procter & Gamble reported fiscal third-quarter 2026 results for the period ended March 31, 2026, with net sales of $21.2 billion, up 7%, and core EPS of $1.59, up 3%. Diluted EPS of $1.63 included a gain from the dissolution of the Glad joint venture, and the company now expects fiscal 2026 EPS toward the lower end of its guidance range, citing higher investment in innovation and demand creation.
Key points
- Net sales $21.2 billion, up 7%; organic sales up 3%
- Diluted EPS $1.63, up 6%, driven by Glad joint venture gain; core EPS $1.59, up 3%
- Core operating margin down 80 basis points; fiscal 2026 EPS now expected toward lower end of guidance range
- Returned $3.2 billion to shareowners, including $2.5 billion in dividends and over $600 million in buybacks
The filing
Written by AI on Nov 8, 2026, 2:16 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.